Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008.
Articolo
Data di Pubblicazione:
2008
Citazione:
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008 / R., Flisiak; S. V., Feinman; M., Jablkowski; A., Horban; W., Kryczka; W., Halota; J. E., Heathcote; G., Mazzella; Vandelli, Carmen; J. S., Liz; R., Crabbé; P., Scalfaro; And H., Porchet. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - ELETTRONICO. - 48:(2008), pp. S62-S62.
Abstract:
not applicable
Tipologia CRIS:
Articolo su rivista
Keywords:
not applicable
Elenco autori:
R., Flisiak; S. V., Feinman; M., Jablkowski; A., Horban; W., Kryczka; W., Halota; J. E., Heathcote; G., Mazzella; Vandelli, Carmen; J. S., Liz; R., Crabbé; P., Scalfaro; And H., Porchet
Link alla scheda completa:
Pubblicato in: